Fusen Pharmaceutical Co., Ltd. (HK:1652) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Fusen Pharmaceutical Co., Ltd. successfully held its Annual General Meeting (AGM) on May 28, 2024, where all proposed resolutions were overwhelmingly approved by shareholders. Key resolutions included the adoption of audited financial statements, re-election of directors, and the re-appointment of KPMG as auditors. Shareholders also granted the directors general mandates to manage share issuances and repurchases, indicating strong investor support for the company’s governance.
For further insights into HK:1652 stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue